Peripartum cardiomyopathy
- PMID: 16215357
- DOI: 10.1097/01.ccm.0000183500.47273.8e
Peripartum cardiomyopathy
Abstract
Objective: To provide a review of the cardiac and obstetrical literature regarding the development of peripartum cardiomyopathy and, in particular, to examine risk factors, incidence, diagnosis, prognosis, and evidence-based treatment modalities.
Design: An extensive review of the current literature.
Results: Peripartum cardiomyopathy is a cardiomyopathy of unknown cause that occurs in pregnant females, most commonly in the early postpartum period. It shares many clinical characteristics with idiopathic dilated cardiomyopathy but occurs at a younger age and is associated with a better prognosis. Diagnosis is based upon the clinical presentation of congestive heart failure and objective evidence of left ventricular systolic dysfunction. Conventional pharmacologic therapy for congestive heart failure, such as diuretics, digoxin, angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and beta-adrenergic blockers, are routinely used and are quite effective. For those patients who remain refractory to conventional pharmacologic therapy, cardiac transplantation and mechanical circulatory support are viable options.
Conclusion: Mortality rates in peripartum cardiomyopathy have decreased, and this is most likely related to advances over the past 5 yrs in medical therapy for heart failure. Aggressive use of implantable defibrillators has significantly reduced the risk of sudden death in these patients. For >50% of peripartum cardiomyopathy patients, left ventricular function normalizes with pharmacologic therapy. However, subsequent pregnancies almost always are associated with recurrence of left ventricular systolic dysfunction.
Similar articles
-
Peripartum cardiomyopathy.Minerva Cardioangiol. 2006 Jun;54(3):331-6. Minerva Cardioangiol. 2006. PMID: 16733507 Review.
-
Safe and Effective Use of Pharmacologic and Device Therapy for Peripartum Cardiomyopathy.Pharmacotherapy. 2016 Sep;36(9):955-70. doi: 10.1002/phar.1795. Epub 2016 Jul 29. Pharmacotherapy. 2016. PMID: 27373996 Review.
-
Peripartum cardiomyopathy: a review.Tex Heart Inst J. 2012;39(1):8-16. Tex Heart Inst J. 2012. PMID: 22412221 Free PMC article. Review.
-
Heart failure in pregnant women: is it peripartum cardiomyopathy?Anesth Analg. 2015 Mar;120(3):638-643. doi: 10.1213/ANE.0000000000000597. Anesth Analg. 2015. PMID: 25695578 Review.
-
Peripartum Cardiomyopathy.Circulation. 2016 Apr 5;133(14):1397-409. doi: 10.1161/CIRCULATIONAHA.115.020491. Circulation. 2016. PMID: 27045128 Review.
Cited by
-
Peripartum cardiomyopathy: ten year experience at a tertiary care hospital in Pakistan.BMC Res Notes. 2013 Dec 1;6:495. doi: 10.1186/1756-0500-6-495. BMC Res Notes. 2013. PMID: 24289218 Free PMC article.
-
An obstetric emergency called peripartum cardiomyopathy!J Emerg Trauma Shock. 2010 Jan;3(1):39-42. doi: 10.4103/0974-2700.58664. J Emerg Trauma Shock. 2010. PMID: 20165720 Free PMC article.
-
Peripartum cardiomyopathy: the need for a national database.Neth Heart J. 2011 Mar;19(3):126-133. doi: 10.1007/s12471-011-0083-7. Epub 2011 Jan 27. Neth Heart J. 2011. PMID: 21475400 Free PMC article.
-
Left Hemiplegia: An Unusual Presentation of Peripartum Cardiomyopathy (PPCM).J Obstet Gynaecol India. 2013 Mar;63(1):74-5. doi: 10.1007/s13224-012-0161-9. Epub 2012 Jun 1. J Obstet Gynaecol India. 2013. PMID: 24431608 Free PMC article. No abstract available.
-
[Peripartum cardiomyopathy: interdisciplinary challenge].Anaesthesist. 2013 May;62(5):343-54. doi: 10.1007/s00101-013-2167-9. Anaesthesist. 2013. PMID: 23584315 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous